WA
AEON icon

Whitebox Advisors’s AEON Biopharma AEON Stock Holding History

Whitebox Advisors’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,181
Closed -$3.03M – 572
2022
Q4 		$3.03M Hold
4,181
– – 0.08% 125
2022
Q3 		$2.96M Hold
4,181
– – 0.08% 126
2022
Q2 		$2.95M Hold
4,181
– – 0.09% 114
2022
Q1 		$2.94M Sell
4,181
-300
-7% -$210K 0.06% 121
2021
Q4 		$3.13M Hold
4,481
– – 0.06% 116
2021
Q3 		$3.14M Sell
4,481
-33
-0.7% -$23K 0.07% 105
2021
Q2 		$3.13M Buy
+4,514
New +$3.16M 0.06% 99

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Whitebox Advisors's AEON Position: Q1 2023 in Review

Whitebox Advisors sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 4,181 shares — an estimated $3.03M sold.

Whitebox Advisors first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $3.14M in Q3 2021. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Whitebox Advisors reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Whitebox Advisors sold 4,181 AEON Biopharma shares in Q1 2023, an estimated $3.03M.
  • Whitebox Advisors first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
  • Whitebox Advisors's AEON Biopharma position peaked at $3.14M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.